Research on the SARS-CoV-2 virus itself. Covers antiviral trials, antibody neutralization, viral escape, and rapid detection methods.
A new study analyzing 8 cohorts of COVID-19 patients found that antibody responses in previously infected individuals were relatively stable, providing protection from reinfection unless the new infection was the Omicron variant. Vaccination also boosted protection, with rapid immune responses observed even after a single vaccine dose.
Scientists found a connection between the SARS-CoV-2 virus and the production of misfolded proteins called amyloids, which can cause complex symptoms and damage in organs such as the heart and kidneys. The researchers' discovery may help explain why COVID-19 often affects multiple parts of the body.
A new study by Gladstone Institutes and UC San Francisco found that infection with the Omicron variant provides weak immune response in unvaccinated individuals, failing to confer broad protection against other variants. In contrast, vaccinated individuals show stronger immunity against multiple COVID-19 strains.
Researchers at Nagoya University developed a device combining an air-curtain and LED irradiation to inactivate viruses in close environments. The technology blocks exhaled air and destroys virus particles, inactivating 99.9% of COVID-19 particles.
Researchers evaluated various vaccination, testing, and surveillance measures to control Omicron variant spread on a university campus. The study found that routine surveillance and vaccination efforts were effective in reducing case numbers and hospitalizations.
Two studies found that a third dose of mRNA vaccine generates high enough antibody levels to neutralize BA.2 and deltacron, as well as other omicron sublineage variants. Booster shots show stronger protection against these variants than just two doses, particularly against deltacron.
A recent study reveals that nearly half of SARS-CoV-2 variants contain the same three mutations, which together improve the virus's ability to infect human cells and evade the immune system. The combination of K417, E484, and N501 mutations enhances viral fitness by balancing positive and negative selection pressures.
A study published in PLOS Medicine found that mRNA vaccines show better protection against COVID-19 variants compared to viral vector vaccines. The research, conducted among healthcare workers, revealed higher neutralizing antibody responses in mRNA vaccine recipients against VOCs, including Omicron.
A new study found that hormone replacement therapy within six months of COVID-19 diagnosis was associated with a 78% reduction in all-cause mortality in women. This suggests estrogen may offer protective effects against COVID-19 severity, explaining the lower hospitalization and death rates among women compared to men.
A new analysis of nationally representative data reveals a significant increase in the impact of HPV vaccination efforts, leading to decreased prevalence of cancer-causing HPV infections among both vaccinated and unvaccinated females. The study found that vaccination has directly protected individuals and generated herd effects, reduci...
New research published in CMAJ found that 11% of patients discharged from COVID-19 hospitalization were readmitted or died within 30 days. Notably, the rates of readmission were consistent with admissions for other medical conditions.
Researchers have trained sniffer dogs to detect SARS-CoV-2 in airport passengers with high accuracy, comparable to PCR swab tests. The dogs' performance was found to be robust across various scenarios, including low prevalence populations, suggesting their potential for widespread use in screening.
Researchers at Gwangju Institute of Science and Technology have developed a new bioinformatics pipeline, CRESSP, to investigate the mechanism underlying autoimmune diseases following SARS-CoV-2 infection. The tool identified potential epitopes responsible for COVID-related autoimmune diseases and predicted cross-reactive epitopes of di...
Researchers at UC San Diego School of Medicine found that COVID-19, MIS-C and Kawasaki disease share similar underlying molecular patterns. The study reveals that MIS-C is a more severe version of the immune response than KD, with potential implications for improved disease diagnosis and treatment.
A world-first study reveals why people with COPD are at higher risk of developing severe COVID-19. Researchers found that COPD airway cells had a 24-fold greater infection with SARS-CoV-2, leading to increased viral load and inflammatory responses.
Researchers compared SARS-CoV-2 antibody titers after Pfizer-BioNTech and Moderna COVID-19 vaccines in immunosuppressed patients. The study found differing antibody responses among these individuals, who have decreased immune responses to standard vaccines.
Researchers found that a single mRNA vaccine booster shot can provide the same level of protection as three doses, making it a promising investment for resource-poor countries. The study suggests that this strategy could benefit billions of people worldwide and help combat emerging COVID-19 variants.
Researchers visualized how J08 binds to different SARS-CoV-2 variants, revealing its flexibility and effectiveness. The antibody's ability to withstand mutations suggests it will remain effective against future variants.
Researchers created human mini-kidneys that mimic diabetic kidneys, finding increased susceptibility to SARS-CoV-2 infection and a critical role for the ACE2 receptor. The study provides new insights into the link between diabetes and COVID-19 disease.
Researchers at Gladstone Institutes have developed a novel class of therapeutics called feedback disruptors that target viral proteins' negative feedback loops. These drugs break the genetic feedback circuits, causing infected cells to self-destruct and stopping infection in its tracks.
Patients who experienced severe systemic inflammation during hospitalization for Covid-19 have a higher risk of dying within one year after seemingly recovering. Prescription of steroids upon discharge from hospital significantly reduces this risk, with effects seen even in the most severe cases.
Researchers found significantly higher levels of MMP-2 and MMP-8 in tracheal aspirate samples from COVID-19 patients, contributing to inflammation and tissue damage. The study's findings suggest a novel mechanism underlying severe lung complications and potential new therapeutic targets.
Researchers found that MS patients treated with Rituximab who have higher B cell counts of 40/µL or more develop protective levels of antibodies after vaccination. This suggests that measuring B cell level before vaccination is crucial for increasing the chance of a positive response.
Research found that SARS-CoV-2 relies on human transmembrane proteins, especially IFITM2, to replicate efficiently and produce infectious viruses. Antibodies targeting IFITM2 can protect lung cells from infection, suggesting a promising therapeutic approach by targeting host factors instead of viral ones.
A follow-up study published in The Lancet Respiratory Medicine found that half of people hospitalized with COVID-19 have at least one symptom two years after infection. Long COVID symptoms persist, affecting quality of life, mental health, and healthcare use.
A recent study found that obesity, impaired blood glucose metabolism, and high blood pressure significantly increase the risk of dying from COVID-19 in young and middle-aged people. Researchers analyzed data from the European case registry LEOSS and found that patients with all three conditions had a similar increased risk of death as ...
A Cornell-led study found that underestimating people's COVID concerns can have severe consequences, including undermining cooperation and trust. The researchers analyzed over 1 million responses from mid-2020 and discovered significant disparities in concern levels between different racial and ethnic groups. Hispanic, Black, and Asian...
Researchers argue that national strategies ignore pandemic's early lessons on chronic diseases and their disproportionate impact on underserved populations. They recommend incorporating prevention and control of chronic diseases into existing policies.
A systematic review and meta-analysis of 81 studies found that COVID-19 patients with cancer had a higher risk of death compared to those without cancer. Younger age, lung, and hematologic cancers were identified as risk factors for poor outcomes from COVID-19
A University of Washington model found that the body's ability to create cloned immune cells falls significantly with age, leading to increased susceptibility to COVID-19 in the elderly. The study suggests that genetic limits on cell division may play a role in the devastating effects of COVID-19 on older adults.
Serial self-testing with untrained individuals revealed a high frequency of procedural steps errors and accurate interpretations were inconsistent. The study suggests that self-performed RADT may not be suitable for mass screening in the workplace.
Researchers found that copper-coated surfaces significantly reduced viral load after one hour, while silver-coated surfaces had no effect on infectivity. The team investigated the antiviral properties of various metal-based sacrificial anodes and discovered a clear antiviral effect of copper against Sars-Cov-2.
Researchers found that individuals with a diverse population of macrophage cells, which include M2 and regulatory macrophages, are better protected against severe COVID-19. The study suggests that a balance between pro-inflammatory and anti-inflammatory responses is key to preventing the worst symptoms.
A study found that vaccines induce immune responses beyond neutralizing antibodies, involving T cells and the Fc receptor, to control viral replication and prevent severe disease. The researchers observed dose-dependent effects on these immune mechanisms, providing insights for future vaccine design and boosting.
A new study by Children's Hospital of Philadelphia found that neighborhood poverty and crowding are associated with higher rates of COVID-19 in pregnancy. Researchers analyzed data from over 5,991 pregnant patients and found disparities in SARS-CoV-2 positivity among different racial and ethnic groups.
Four rapid antigen tests were found to be less sensitive to the Delta variant than the Omicron strain. The study suggests that continuous assessment and updating are needed for these tests to remain effective in detecting COVID-19 infections. Continuous improvement is necessary to ensure they meet public health testing goals.
Scripps Research scientists found that COVID-19 patients develop more robust antibodies against coronaviruses causing common colds and SARS-CoV-1 and MERS-CoV. This increased antibody response may lead to improved vaccine development, targeting a broader range of viruses.
Researchers at Binghamton University have developed a system that kills SARS-CoV-2 viruses using UVC light, with optimal results achieved between 260-280 nanometers. The study's findings provide a scientific basis for standardizing and regulating claims from manufacturers of UV disinfectant devices.
A new study led by UTHealth Houston found that patients with recent cancer diagnoses had a higher risk of death and hospitalization, but those with cancer more than one year ago were not significantly associated with increased mortality. The research also confirmed racial disparities in COVID-19 outcomes among cancer patients.
A new lab test has been developed by Rutgers scientists to identify COVID-19 variants. The test uses molecular beacon technology and can detect eight different mutations in the spike protein, increasing the transmissibility of the virus and evading immune defenses.
A German Federal Institute for Risk Assessment (BfR) study published in Food Microbiology found that coronaviruses on glass are stable but can be inactivated through conventional rinsing processes. Commercial dish washing detergents and manual glass washers were shown to effectively remove coronaviruses from drinking glasses.
State bans on affirmative action policies are associated with lower enrollment of underrepresented minority students in public medical schools. The study found a 5.5 percentage point decrease in enrollment of underrepresented students relative to control schools.
A recent study presented at the 2022 ARRS Annual Meeting found that COVID-19 infection significantly impacted lung cancer screening in diverse inner-city populations. The research revealed that approximately 9% of participants developed COVID-19 during the pandemic, with mortality rates reaching 6.9%.
A study by Children's National Hospital found that elevated anxiety, depression, and stress in pregnant women can alter key features of the fetal brain, decreasing their offspring's cognitive development at 18 months. This alteration also increased internalizing and dysregulation behaviors.
A new study using a citizen science board of people affected by Long Covid identifies key research areas, including treatment, diagnosis, and disease management. The findings highlight the need for clear diagnoses and access to care that meets their multidimensional needs.
The study found that T-cell immunity was effective against Omicron variants in approximately 90% of vaccinated Europeans. The researchers identified a specific HLA-DRB1*03:01 variant that allowed the virus to evade immune recognition, particularly affecting individuals with this genetic variation.
Researchers from Osaka University have developed an engineered ACE2 decoy that effectively reduces the rate and severity of infection with the Omicron variant under laboratory conditions. The decoy mimics the SARS-CoV-2 receptor, preventing the virus from binding to cells and entering them.
A recent study found that COVID-19 vaccination significantly reduces the risk of infection, hospitalization, and death among heart transplant recipients. The study, published in JAMA Cardiology, compared vaccinated and unvaccinated patients at a single center and showed a notable difference in outcomes.
A new study published in the Canadian Medical Association Journal found that unvaccinated individuals pose a significant risk to vaccinated people, even when vaccination rates are high. The research suggests that mixing between unvaccinated and vaccinated populations can lead to substantial new infections among the vaccinated.
Researchers found that a common asthma medication can bind to and block the Nsp1 protein of SARS-CoV-2, preventing it from shutting down vital proteins in human immune cells. The study suggests that targeting this region could be an effective way to reduce damage inflicted by the virus.
Patients hospitalized with omicron required similar levels of respiratory support and intensive care as those with delta variants, according to a Johns Hopkins study. Omicron infections should not be underestimated due to comparable severe disease risks.
A UCLA-led team found that an abnormally suppressed immune system, not a persistently hyperactive one, may be to blame for some cases of long COVID-19. The study suggests boosting immunity in those individuals could be a treatment option.
Researchers at George Mason University developed Ha-CoV-2, a non-replicating rapid SARS-CoV-2 pseudovirus system to measure antibody blocking efficacy. The technology can rapidly assess neutralizing antibodies and has significant impacts for pandemic control strategies.
Researchers at Gwangju Institute of Science and Technology (GIST) have developed a new technique to easily visualize viruses using an optical microscope, called the Gires-Tournois immunoassay platform. The platform uses 'slow light' technology to detect coronavirus particles by slowing down light that gets reflected around them.
The World Health Organization recommends Pfizer's nirmatrelvir/ritonavir for non-severe COVID-19 patients at highest risk of hospitalization, reducing hospital admissions by 84 per 1,000 patients. The guideline also suggests using remdesivir for high-risk patients and acknowledges cost and resource implications.
Researchers at Duke University discovered that SARS-CoV-2, the virus causing COVID-19, can directly infect and damage specific types of kidney cells. The virus hijacks the cell's machinery to replicate, leading to structural damage and increased production of viral particles.
A new study assesses the degree and duration of protection against COVID-19 associated with natural immunity in 120,000 unvaccinated individuals. Researchers found that those who previously tested positive for SARS-CoV-2 had lower rates of subsequent COVID-19 infections.
A large-scale study found a link between SARS-CoV-2 mRNA vaccinations and an increased risk of myocarditis, particularly among younger individuals. The study, published in JAMA Cardiology, analyzed data from Denmark, Finland, Norway, and Sweden.
Exposure to certain air pollutants is associated with a greater likelihood of testing positive for SARS-CoV-2. The study found a significant link between traffic-related pollutants and COVID-19 infection risk, suggesting that improving air quality may have public health benefits.
The study found an increase in mass shootings and proportion of women and children shot, highlighting worsening structural inequalities. The researchers emphasize the need for investment in public education, employment, and social services to address gun violence.